Propanc Biopharma Announces Nasdaq Uplisting And Pricing Of $4 Million Public Offering
Aug 14 (Reuters) - Propanc Biopharma Inc PPCB.PK:
PROPANC BIOPHARMA ANNOUNCES NASDAQ UPLISTING AND PRICING OF $4 MILLION PUBLIC OFFERING
PROPANC BIOPHARMA INC - PRICES PUBLIC OFFERING OF 1,000,000 SHARES AT $4.00 EACH
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.